Agarwood from Aquilaria plants, also known as Chen Xiang (沉香), is traditionally used for the treatment of abdominal pain and as a sedative. Because of the great demand and the rareness of agarwood, extensive harvesting of Aquilaria plants has nearly led to the extinction of the species. To fully utilize this resource, the use of different parts of Aquilaria needs to be investigated. This article will focus on the pharmacological properties and the mechanism of action of different parts of Aquilaria plants.
{"title":"Medicinal uses of agarwood","authors":"Lertnimitphun Peeraphong","doi":"10.4103/CMAC.CMAC_43_21","DOIUrl":"https://doi.org/10.4103/CMAC.CMAC_43_21","url":null,"abstract":"Agarwood from Aquilaria plants, also known as Chen Xiang (沉香), is traditionally used for the treatment of abdominal pain and as a sedative. Because of the great demand and the rareness of agarwood, extensive harvesting of Aquilaria plants has nearly led to the extinction of the species. To fully utilize this resource, the use of different parts of Aquilaria needs to be investigated. This article will focus on the pharmacological properties and the mechanism of action of different parts of Aquilaria plants.","PeriodicalId":72584,"journal":{"name":"Chinese medicine and culture : official publication of Shanghai University of Traditional Chinese Medicine","volume":"4 1","pages":"260 - 265"},"PeriodicalIF":0.0,"publicationDate":"2021-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42871250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
There are over 250 species of cinnamon. Each has its distinct morphology and phytochemical composition, which may result in varied therapeutic effects. However, clinical studies have rarely put emphasis on the species of cinnamon being investigated. This scoping review summarized the clinical evidence of Cinnamomum cassia (also known as Cinnamomum aromaticum), which is the species of cinnamon used in traditional Chinese medicine. Electronic searches were conducted on PubMed from its inception till August 2021. Clinical studies that were published in English, stating monotherapy with Cinnamomum cassia, Cinnamomum aromaticum, or “Rou Gui” were included. The 15 included clinical studies investigated the effects of Cinnamomum cassia on type-2 diabetes patients (n=7), and healthy adults (n=8). In the type 2 diabetes population, Cinnamomum cassia supplementation of as low as 1 g/d seemed to improve HbA1c in only poorly controlled diabetes. In the healthy population, Cinnamomum cassia supplementation appeared to influence blood glucose response in a dose-dependent manner, with current studies indicating a minimum of 5 g/dto achieve significant improvement. Studies also showed potential improvement in insulin sensitivity with prolonged Cinnamomum cassia supplementation. However, there were apparent heterogeneity among studies and uncertainties regarding the accuracy of reported cinnamon species. Therefore, the therapeutic effects of Cinnamomum cassia remain inconclusive. Future larger scale and more rigorous clinical studies, with clear identification of Cinnamomum species used, are needed for more conclusive evidence of the clinical effects of Cinnamomum cassia.
{"title":"Clinical Research on Cinnamomi Cortex: A Scoping Review","authors":"Hsiewe Ying Tan, W. Nabil, Hong-Xi Xu","doi":"10.4103/CMAC.CMAC_42_21","DOIUrl":"https://doi.org/10.4103/CMAC.CMAC_42_21","url":null,"abstract":"There are over 250 species of cinnamon. Each has its distinct morphology and phytochemical composition, which may result in varied therapeutic effects. However, clinical studies have rarely put emphasis on the species of cinnamon being investigated. This scoping review summarized the clinical evidence of Cinnamomum cassia (also known as Cinnamomum aromaticum), which is the species of cinnamon used in traditional Chinese medicine. Electronic searches were conducted on PubMed from its inception till August 2021. Clinical studies that were published in English, stating monotherapy with Cinnamomum cassia, Cinnamomum aromaticum, or “Rou Gui” were included. The 15 included clinical studies investigated the effects of Cinnamomum cassia on type-2 diabetes patients (n=7), and healthy adults (n=8). In the type 2 diabetes population, Cinnamomum cassia supplementation of as low as 1 g/d seemed to improve HbA1c in only poorly controlled diabetes. In the healthy population, Cinnamomum cassia supplementation appeared to influence blood glucose response in a dose-dependent manner, with current studies indicating a minimum of 5 g/dto achieve significant improvement. Studies also showed potential improvement in insulin sensitivity with prolonged Cinnamomum cassia supplementation. However, there were apparent heterogeneity among studies and uncertainties regarding the accuracy of reported cinnamon species. Therefore, the therapeutic effects of Cinnamomum cassia remain inconclusive. Future larger scale and more rigorous clinical studies, with clear identification of Cinnamomum species used, are needed for more conclusive evidence of the clinical effects of Cinnamomum cassia.","PeriodicalId":72584,"journal":{"name":"Chinese medicine and culture : official publication of Shanghai University of Traditional Chinese Medicine","volume":"4 1","pages":"243 - 250"},"PeriodicalIF":0.0,"publicationDate":"2021-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48985816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Shan Ci Gu (山慈菇 Pseudobulbus Cremastrae seu Pleiones), a rare and precious traditional Chinese medicine, has attracted attention for the treatment of various cancers and bacterial infections. According to the Pharmacopoeia of the People's Republic of China, Pseudobulbus Cremastrae seu Pleionesis sourced from the pseudobulbs of three plants in the Orchidaceae family: Cremastra appendiculata (D. Don) Makino, Pleione bulbocodioides (Franch.) Rolfe, and Pleione yunnanensis Rolfe. Extracts from Pseudobulbus Cremastrae seu Pleiones are used for the treatment of tumors, burns, and frostbite. The aims of this review are to provide information on the historical and herbological origins of Pseudobulbus Cremastrae seu Pleiones, to summarize research conducted on its phytochemical and biological activities over the last twenty years, and to detail planting efforts.
山慈姑(山慈菇 假球茎（Pseudobulbulus Cremastrae seu Pleiones）是一种罕见而珍贵的中药，因其治疗各种癌症和细菌感染而备受关注。根据《中华人民共和国药典》记载，假球茎兰来源于兰科三种植物的假球茎：附兰（Cremastra appendiculata，D.Don）Makino、球柄花（Pleione bulmbocodioides，Franch）Rolfe和云南花（Pleion yunnanensis Rolfe）。假球茎提取物用于治疗肿瘤、烧伤和冻伤。本综述的目的是提供关于假球茎的历史和草本起源的信息，总结过去二十年来对其植物化学和生物活性的研究，并详细介绍种植工作。
{"title":"Rare and Precious Chinese Materia Medica: Pseudobulbus Cremastrae seu Pleiones","authors":"Hisayoshi Norimoto, Chiaki Murayama, Feng Zhao, Hong-Yan Wei","doi":"10.4103/CMAC.CMAC_46_21","DOIUrl":"https://doi.org/10.4103/CMAC.CMAC_46_21","url":null,"abstract":"Shan Ci Gu (山慈菇 Pseudobulbus Cremastrae seu Pleiones), a rare and precious traditional Chinese medicine, has attracted attention for the treatment of various cancers and bacterial infections. According to the Pharmacopoeia of the People's Republic of China, Pseudobulbus Cremastrae seu Pleionesis sourced from the pseudobulbs of three plants in the Orchidaceae family: Cremastra appendiculata (D. Don) Makino, Pleione bulbocodioides (Franch.) Rolfe, and Pleione yunnanensis Rolfe. Extracts from Pseudobulbus Cremastrae seu Pleiones are used for the treatment of tumors, burns, and frostbite. The aims of this review are to provide information on the historical and herbological origins of Pseudobulbus Cremastrae seu Pleiones, to summarize research conducted on its phytochemical and biological activities over the last twenty years, and to detail planting efforts.","PeriodicalId":72584,"journal":{"name":"Chinese medicine and culture : official publication of Shanghai University of Traditional Chinese Medicine","volume":"4 1","pages":"211 - 220"},"PeriodicalIF":0.0,"publicationDate":"2021-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48592260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ophiocordyceps sinensis and Cordyceps militaris both contain many bioactive compounds that confer potential therapeutic benefits. This review discusses the possible use of cultivated C. militaris as an effective substitute for native O. sinensis in the face of ever-increasing prices of O. sinensis because of its short supply. On the one hand, cultivated C. militaris contains higher levels of cordycepin when compared with that of wild-type O. sinensis and cultivation of C. militaris has been shown to be capable of reducing the risk of heavy metal contamination. On the other hand, there is a paucity of robust in vivo studies and randomized controlled tests comparing the pharmacology and use of C. militaris and O. sinensis. For extraction of cordycepin as western-style tablets, the use of cultivated C. militaris rather than O. sinensis represents the most appropriate future approach. For many other purposes, comparative pharmacology and clinical trials are in urgent needs.
{"title":"Cultivated Cordyceps: A Tale of Two Treasured Mushrooms","authors":"A. Anyu, Wen-hui Zhang, Qi-He Xu","doi":"10.4103/CMAC.CMAC_41_21","DOIUrl":"https://doi.org/10.4103/CMAC.CMAC_41_21","url":null,"abstract":"Ophiocordyceps sinensis and Cordyceps militaris both contain many bioactive compounds that confer potential therapeutic benefits. This review discusses the possible use of cultivated C. militaris as an effective substitute for native O. sinensis in the face of ever-increasing prices of O. sinensis because of its short supply. On the one hand, cultivated C. militaris contains higher levels of cordycepin when compared with that of wild-type O. sinensis and cultivation of C. militaris has been shown to be capable of reducing the risk of heavy metal contamination. On the other hand, there is a paucity of robust in vivo studies and randomized controlled tests comparing the pharmacology and use of C. militaris and O. sinensis. For extraction of cordycepin as western-style tablets, the use of cultivated C. militaris rather than O. sinensis represents the most appropriate future approach. For many other purposes, comparative pharmacology and clinical trials are in urgent needs.","PeriodicalId":72584,"journal":{"name":"Chinese medicine and culture : official publication of Shanghai University of Traditional Chinese Medicine","volume":"4 1","pages":"221 - 227"},"PeriodicalIF":0.0,"publicationDate":"2021-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49236954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
X. Chen, Junyi Duan, Kaidong Liu, Yi-fan Guo, Dong Wang, Ming-wang Liu, Dan Zhao, Bei Li, Hong Li, Xuan Wang
Huang Jing (黄精 Polygonati Rhizoma, PR) was first documented as a herbal medicine in Ming Yi Bie Lu (《名医别录》 Miscellaneous Records of Famous Physicians) in China. However, there was no comprehensive review on the botany, traditional uses, and pharmacological effects of PR till now. In this study, the botany, traditional uses including Taoist medicine, and pharmacological effects of PR were reviewed and summarized to provide insights on drug development of PR. In Taoist medicine, PR maintains agerasia and helps prolong human life-span, and is used for fasting (Bigu). In the Zhong Guo Yao Dian (《中国药典》Chinese Pharmacopeia) version 2020, PR exerts replenishing qi and nourishing yin, invigorating the spleen, moistening the lung, and strengthening the kidney. Pharmacological studies show that PR has effects of anti-oxidation, anti-diabetes, anti-osteoporosis, anti-cancer, anti-hyperlipidemia, cardiomyocyte protection, immunomodulatory, and thus can be used for treatment of infertility, anti-microorganisms, and improving sleep and memory. In conclusion, PR may play a potential role for chronic disease management and health preservation and this very role deserves a more in-depth research.
{"title":"Botany, Traditional Uses, and Pharmacology of Polygonati Rhizoma","authors":"X. Chen, Junyi Duan, Kaidong Liu, Yi-fan Guo, Dong Wang, Ming-wang Liu, Dan Zhao, Bei Li, Hong Li, Xuan Wang","doi":"10.4103/CMAC.CMAC_39_21","DOIUrl":"https://doi.org/10.4103/CMAC.CMAC_39_21","url":null,"abstract":"Huang Jing (黄精 Polygonati Rhizoma, PR) was first documented as a herbal medicine in Ming Yi Bie Lu (《名医别录》 Miscellaneous Records of Famous Physicians) in China. However, there was no comprehensive review on the botany, traditional uses, and pharmacological effects of PR till now. In this study, the botany, traditional uses including Taoist medicine, and pharmacological effects of PR were reviewed and summarized to provide insights on drug development of PR. In Taoist medicine, PR maintains agerasia and helps prolong human life-span, and is used for fasting (Bigu). In the Zhong Guo Yao Dian (《中国药典》Chinese Pharmacopeia) version 2020, PR exerts replenishing qi and nourishing yin, invigorating the spleen, moistening the lung, and strengthening the kidney. Pharmacological studies show that PR has effects of anti-oxidation, anti-diabetes, anti-osteoporosis, anti-cancer, anti-hyperlipidemia, cardiomyocyte protection, immunomodulatory, and thus can be used for treatment of infertility, anti-microorganisms, and improving sleep and memory. In conclusion, PR may play a potential role for chronic disease management and health preservation and this very role deserves a more in-depth research.","PeriodicalId":72584,"journal":{"name":"Chinese medicine and culture : official publication of Shanghai University of Traditional Chinese Medicine","volume":"4 1","pages":"251 - 259"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47463569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Overview of research trends in precious chinese medicines","authors":"Hong Xu, Zhi-Qiu Lin","doi":"10.4103/CMAC.CMAC_45_21","DOIUrl":"https://doi.org/10.4103/CMAC.CMAC_45_21","url":null,"abstract":"","PeriodicalId":72584,"journal":{"name":"Chinese medicine and culture : official publication of Shanghai University of Traditional Chinese Medicine","volume":"4 1","pages":"197 - 200"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43267676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Saffron (Stigma Croci) is an autumn-flowering perennial plant, and its use has a history of over 3500 years. Saffron has often been considered as the costliest medicinal plant, a premium spice, and the best dye with a golden yellowish color. Iran currently produces the finest quality saffron and dominates its global production (>90%). Other countries such as Australia, Canada, the USA, China, and some countries in Central Africa, produce saffron at a lower yield. In China, saffron is celebrated as “red gold” owing to the red stigmas of the flower and its price, which is comparable to the price of gold. Saffron has been one of the most attractive traditional Chinese medicine (TCM) herbs in the Zhong Guo Yao Dian (《中国药典》Chinese Pharmacopoeia) since its inclusion in the 2005 edition. The earliest use of saffron in TCM was recorded in the Ben Cao Shi Yi (《本草拾遗》Supplement to Materia Medica) written during the Tang dynasty (741 A.D.). However, saffron grown in inland China has been widely mistaken as originating from Tibet. This is because its Chinese name begins with “Xi” or “Zang,” which sounds similar to its Tibetan name (“Xi Zang”). In this review, we clarify the origin of saffron and its introduction to China and summarize its various applications.
{"title":"The history of saffron in China: From its origin to applications","authors":"R. Dai, Wan Najbah Nik Nabil, Hong-Xi Xu","doi":"10.4103/CMAC.CMAC_38_21","DOIUrl":"https://doi.org/10.4103/CMAC.CMAC_38_21","url":null,"abstract":"Saffron (Stigma Croci) is an autumn-flowering perennial plant, and its use has a history of over 3500 years. Saffron has often been considered as the costliest medicinal plant, a premium spice, and the best dye with a golden yellowish color. Iran currently produces the finest quality saffron and dominates its global production (>90%). Other countries such as Australia, Canada, the USA, China, and some countries in Central Africa, produce saffron at a lower yield. In China, saffron is celebrated as “red gold” owing to the red stigmas of the flower and its price, which is comparable to the price of gold. Saffron has been one of the most attractive traditional Chinese medicine (TCM) herbs in the Zhong Guo Yao Dian (《中国药典》Chinese Pharmacopoeia) since its inclusion in the 2005 edition. The earliest use of saffron in TCM was recorded in the Ben Cao Shi Yi (《本草拾遗》Supplement to Materia Medica) written during the Tang dynasty (741 A.D.). However, saffron grown in inland China has been widely mistaken as originating from Tibet. This is because its Chinese name begins with “Xi” or “Zang,” which sounds similar to its Tibetan name (“Xi Zang”). In this review, we clarify the origin of saffron and its introduction to China and summarize its various applications.","PeriodicalId":72584,"journal":{"name":"Chinese medicine and culture : official publication of Shanghai University of Traditional Chinese Medicine","volume":"4 1","pages":"228 - 234"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45702270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
194 Introduction Health preservation plays a vital role in traditional Chinese medicine (TCM), and it is dealt with several times in the TCM classic Huang Di Nei Jing (《黄帝内经》 Huangdi’s Internal Classic) compiled thousands of years ago. For example, the chapter Discourse on the True Qi Endowed by Heaven in High Antiquity contains the following description: The sages in ancient times who knew the tenets for cultivating health followed the rules of yin and yang and adjusted the ways to cultivate health. They were moderate in eating and drinking, regular in working and restraint, and avoiding any overstrain. That is why they could maintain a desirable harmony between the mind and the body, enjoy good health, and sustain a long life.[1] Many other well-famed doctors and thinkers throughout the history have contributed inspirational sayings aiming at preserving health. The great physician Zhu Zhenheng (朱震亨) in the Yuan dynasty (1271–1368) observed in his book Dan Xi Xin Fa (《丹溪心法》Danxi’s Experiential Therapy) that: “It is better to take preventive measures ahead of the disease rather than treat the disease after it occurs (与其救疗于有疾之后, 不 若摄养于无疾之先),”[2] with the emphasis of this observation being on the significance of disease prevention. However, these classical intellectual sayings are not well known to most Chinese people as classical form of the Chinese language is no longer in the current use.
{"title":"Shared Wisdom about Health Preservation in Traditional Maltese and Chinese Proverbs","authors":"Kaiwen Zhang, C. Savona-Ventura, Jing Lu","doi":"10.4103/cmac.cmac_29_21","DOIUrl":"https://doi.org/10.4103/cmac.cmac_29_21","url":null,"abstract":"194 Introduction Health preservation plays a vital role in traditional Chinese medicine (TCM), and it is dealt with several times in the TCM classic Huang Di Nei Jing (《黄帝内经》 Huangdi’s Internal Classic) compiled thousands of years ago. For example, the chapter Discourse on the True Qi Endowed by Heaven in High Antiquity contains the following description: The sages in ancient times who knew the tenets for cultivating health followed the rules of yin and yang and adjusted the ways to cultivate health. They were moderate in eating and drinking, regular in working and restraint, and avoiding any overstrain. That is why they could maintain a desirable harmony between the mind and the body, enjoy good health, and sustain a long life.[1] Many other well-famed doctors and thinkers throughout the history have contributed inspirational sayings aiming at preserving health. The great physician Zhu Zhenheng (朱震亨) in the Yuan dynasty (1271–1368) observed in his book Dan Xi Xin Fa (《丹溪心法》Danxi’s Experiential Therapy) that: “It is better to take preventive measures ahead of the disease rather than treat the disease after it occurs (与其救疗于有疾之后, 不 若摄养于无疾之先),”[2] with the emphasis of this observation being on the significance of disease prevention. However, these classical intellectual sayings are not well known to most Chinese people as classical form of the Chinese language is no longer in the current use.","PeriodicalId":72584,"journal":{"name":"Chinese medicine and culture : official publication of Shanghai University of Traditional Chinese Medicine","volume":"4 1","pages":"194 - 196"},"PeriodicalIF":0.0,"publicationDate":"2021-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42169930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
German doctor Gottlieb Olpp played an important role in Sino-German medical exchanges during the late Qing dynasty. During his stay in China for more than 9 years, he wrote a large number of texts related to local Chinese medical and hygienic conditions. In these works, he introduced traditional Chinese medicine (TCM) and its situation at that time but also translated TCM literature. His translations and his achievements facilitated the development of sinology in Germany. Not only was he responsible for the development of the method used by German sinologists in translating TCM literature, but also his work gave an impetus to the combination of academic goals and current considerations in sinology studies. In this way, the study of TCM is the internal force driving the development of sinology.
{"title":"Spread of Traditional Chinese Medicine to the West and the Development of Sinology: A Case Study Based on the Translation of Traditional Chinese Medicine Literature by German Doctor Gottlieb Olpp","authors":"Weimin Yuan","doi":"10.4103/CMAC.CMAC_27_21","DOIUrl":"https://doi.org/10.4103/CMAC.CMAC_27_21","url":null,"abstract":"German doctor Gottlieb Olpp played an important role in Sino-German medical exchanges during the late Qing dynasty. During his stay in China for more than 9 years, he wrote a large number of texts related to local Chinese medical and hygienic conditions. In these works, he introduced traditional Chinese medicine (TCM) and its situation at that time but also translated TCM literature. His translations and his achievements facilitated the development of sinology in Germany. Not only was he responsible for the development of the method used by German sinologists in translating TCM literature, but also his work gave an impetus to the combination of academic goals and current considerations in sinology studies. In this way, the study of TCM is the internal force driving the development of sinology.","PeriodicalId":72584,"journal":{"name":"Chinese medicine and culture : official publication of Shanghai University of Traditional Chinese Medicine","volume":"4 1","pages":"165 - 169"},"PeriodicalIF":0.0,"publicationDate":"2021-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47581594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This article provides an introduction to Michel Boym (1612–1659) and Jean Pierre Abel Rémusat (1788–1832) and examines the research on traditional Chinese medicine (TCM) conducted by the two prominent sinologists. This work points out that Michel Boym introduced TCM to the West and Rémusat was the first to write a doctoral thesis on TCM. A historical overview of the translation, communication and impact of TCM in Europe at that time reveals that this communication of TCM to the West played a significant role in the rise of the study of Sinology in Europe.
{"title":"Boym and Rémusat: Communication of Traditional Chinese Medicine and the Rise of Western Sinology","authors":"Xi-Ping Zhang","doi":"10.4103/CMAC.CMAC_34_21","DOIUrl":"https://doi.org/10.4103/CMAC.CMAC_34_21","url":null,"abstract":"This article provides an introduction to Michel Boym (1612–1659) and Jean Pierre Abel Rémusat (1788–1832) and examines the research on traditional Chinese medicine (TCM) conducted by the two prominent sinologists. This work points out that Michel Boym introduced TCM to the West and Rémusat was the first to write a doctoral thesis on TCM. A historical overview of the translation, communication and impact of TCM in Europe at that time reveals that this communication of TCM to the West played a significant role in the rise of the study of Sinology in Europe.","PeriodicalId":72584,"journal":{"name":"Chinese medicine and culture : official publication of Shanghai University of Traditional Chinese Medicine","volume":"59 8","pages":"137 - 140"},"PeriodicalIF":0.0,"publicationDate":"2021-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41246641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：